Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

B Cell ◽

Lymphocytic Leukaemia ◽

Faculty Opinions recommendation of A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328356.793538169 ◽

2017 ◽

Author(s):

Varsha Gandhi ◽

Prithviraj Bose

Keyword(s):

Monoclonal Antibody ◽

B Cell ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukaemia ◽

Phase 1 ◽

Non Hodgkin Lymphoma ◽

Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia

10.1111/j.1365-2141.2006.06324.x ◽

2006 ◽

Vol 135 (4) ◽

pp. 475-485 ◽

Cited By ~ 17

Author(s):

Mohammad Reza Rezvany ◽

Mahmood Jeddi Tehrani ◽

Claes Karlsson ◽

Jeanette Lundin ◽

Hodjattallah Rabbani ◽

...

Keyword(s):

Monoclonal Antibody ◽

T Cell ◽

B Cell ◽

Lymphocytic Leukaemia ◽

T Cell Repertoire ◽

Cell Repertoire ◽

Ofatumumab,* a novel antiCD20 monoclonal antibody, is active in patients with relapsed or refractory B-cell chronic lymphocytic leukaemia

Inpharma Weekly ◽

10.2165/00128413-200816250-00027 ◽

2008 ◽

Vol &NA; (1625) ◽

pp. 12

Author(s):

&NA;

Keyword(s):

Monoclonal Antibody ◽

B Cell ◽

Lymphocytic Leukaemia ◽

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

Leukemia ◽

10.1038/sj.leu.2403258 ◽

2004 ◽

Vol 18 (3) ◽

pp. 484-490 ◽

Cited By ~ 86

Author(s):

J Lundin ◽

A Porwit-MacDonald ◽

E D Rossmann ◽

C Karlsson ◽

P Edman ◽

...

Keyword(s):

Monoclonal Antibody ◽

B Cell ◽

Immune Reconstitution ◽

Lymphocytic Leukaemia ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Cellular Immune

A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab

10.1111/bjh.14534 ◽

2017 ◽

Vol 177 (2) ◽

pp. 243-253 ◽

Cited By ~ 34

Author(s):

Ahmed Sawas ◽

Charles M. Farber ◽

Marshall T. Schreeder ◽

Mazen Y. Khalil ◽

Daruka Mahadevan ◽

...

Keyword(s):

Monoclonal Antibody ◽

B Cell ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukaemia ◽

Phase 1 ◽

Non Hodgkin Lymphoma ◽

Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia

10.1046/j.1365-2141.2000.02307.x ◽

2000 ◽

Vol 111 (1) ◽

pp. 230-238 ◽

Cited By ~ 26

Author(s):

Mohammad Reza Rezvany ◽

Mahmood Jeddi-Tehrani ◽

Hodjattallah Rabbani ◽

Ulla Ruden ◽

Lennart Hammarstrom ◽

...

Keyword(s):

T Lymphocytes ◽

B Cell ◽

Lymphocytic Leukaemia ◽

Cdr3 Region

Co-Expression of CD2 or CD8 Antigens in B-Cell Chronic Lymphocytic Leukaemia

Acta Clinica Belgica ◽

10.1080/17843286.1994.11718386 ◽

1994 ◽

Vol 49 (3-4) ◽

pp. 183-186 ◽

Cited By ~ 4

Author(s):

D. Brohee ◽

P. Cauchie ◽

P. Neve

Keyword(s):

B Cell ◽

Lymphocytic Leukaemia ◽

Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line

10.1111/j.1365-2141.2005.05699.x ◽

2005 ◽

Vol 130 (6) ◽

pp. 878-889 ◽

Cited By ~ 6

Author(s):

Sonia Minuzzo ◽

Stefano Indraccolo ◽

Valeria Tosello ◽

Erich Piovan ◽

Anna Cabrelle ◽

...

Keyword(s):

Gene Transfer ◽

B Cell ◽

Lymphocytic Leukaemia ◽

Cell Receptor ◽

B Cell Receptor ◽

Surface Immunoglobulin ◽

Intracellular Expression ◽

Immunoglobulin Levels

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

10.1111/j.1365-2141.2007.06974.x ◽

2008 ◽

Vol 140 (6) ◽

pp. 635-643 ◽

Cited By ~ 82

Author(s):

Christophe de Romeuf ◽

Charles-Antoine Dutertre ◽

Magali Le Garff-Tavernier ◽

Nathalie Fournier ◽

Christine Gaucher ◽

...

Keyword(s):

Monoclonal Antibody ◽

Lymphocytic Leukaemia ◽

Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia

Annals of Oncology ◽

10.1007/978-1-4899-7305-4_17 ◽

1991 ◽

pp. 107-113

Author(s):

Antonio Pinto ◽

L. Del Vecchio ◽

A. Carbone ◽

M. Roncadin ◽

R. Volpe ◽

...

Keyword(s):

B Cell ◽

Lymphocytic Leukaemia ◽